PALO ALTO, Calif., March 8, 2011 /PRNewswire/ — Jazz
Pharmaceuticals, Inc. (Nasdaq:
JAZZ) announced today that the company will be providing a
business update at two upcoming investor conferences:
- Kathryn Falberg, the company’s chief financial officer, will
provide an update at the ROTH 23rd Annual OC Growth Stock
Conference in Dana Point, CA on Monday, March 14, 2011 at 4:30 p.m.
- Bruce Cozadd, the company’s chairman and chief executive
officer, will provide an update at Barclays Capital 2011 Global
Healthcare Conference in Miami on Thursday, March 17, 2011 at 11:15
a.m. Eastern Time.
A live webcast of each presentation may be accessed from the
Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.
Please connect to the website prior to the start of the conference
call to ensure adequate time for any software downloads that may be
necessary to listen to the webcast.
An archived version of both webcasts will be available for at
least one week on the Investors section of the company’s website at
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq:
JAZZ) is a specialty pharmaceutical company that identifies,
develops and commercializes innovative treatments for important,
underserved markets in neurology and psychiatry. For further
information see www.jazzpharmaceuticals.com.